VMD - NASDAQ
Viemed Healthcare, Inc.
$9.56
+0.84%Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
At a Glance
Live SnapshotViemed Healthcare, Inc. Cash Conversion Engine
Cash Flow Quality Analysis
FCF Conversion Rate
Moderate conversion rate. Some gap between earnings and cash flow may warrant investigation into working capital or non-cash items.
CapEx Intensity
Very high capital intensity consumes most operating cash flow. Limited flexibility for dividends or debt reduction.
FCF Growth Trend
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Working Capital Impact
Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.
Cash Flow Quality Insight
Capital-intensive growth: Heavy reinvestment limits current cash available but may drive future returns. Assess whether CapEx supports compelling growth opportunities with adequate ROI.
Viemed Healthcare, Inc. Cash Flow Statement
VMD • NASDAQ
| Viemed Healthcare, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||
14.9M | 11.4M | 10.2M | 6.2M | 9.1M | 31.5M | 8.5M | 10.2M | 8.2M | 1.2M | 8.9M | 9.5M | |
28.6M | 25.4M | 21.9M | 15.6M | 11.3M | 9.6M | 6.4M | 3.8M | 2.5M | 1.4M | 955.1K | 385K | |
3.1M | -3.8M | -1.4M | 1.7M | 3.9M | -8.7M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
9.1M | 6.3M | 5.8M | 5.2M | 5.2M | 4.9M | 3.9M | 2.7M | 828K | 0.0 | 0.0 | 0.0 | |
-1.6M | -488K | 921K | 9.1M | 6.6M | 8.1M | 9.8M | 6.5M | 5.3M | 4.3M | 5.8M | 558K | |
(0.0) | (6.8M) | (3.6M) | (0.0) | (1.8M) | (3.3M) | (338K) | (151K) | (0.0) | (0.0) | (0.0) | (0.0) | |
-2.3M | 355K | 7.8M | -10.1M | -13.6M | -10.2M | -9.5M | -748K | -4.9M | -564K | -1.6M | -2.8M | |
51.9M | 39.1M | 45.2M | 27.7M | 22.5M | 35.1M | 19.1M | 22.4M | 12M | 6.4M | 9.4M | 7.6M | |
INVESTING ACTIVITIES | ||||||||||||
-40M | -37.8M | -26.1M | -22.9M | -19.7M | -13M | -13.4M | -6.1M | -4M | -1.7M | -132.6K | -849K | |
-26.3M | -3M | -28.6M | -141K | -599K | -629K | (587.3K) | (813K) | (430K) | (738K) | (0.0) | (0.0) | |
(0.0) | (0.0) | (0.0) | -2M | -593.7K | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
0.0 | 750K | 0.0 | 0.0 | 593.7K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
16.2M | 9.3M | 2.6M | 1.1M | 596K | 5.3M | -13.3K | 813K | 430K | 738K | 0.0 | 0.0 | |
-50.2M | -30.7M | -52.1M | -24M | -19.7M | -8.4M | -12.8M | -5.3M | -3.6M | -936K | -132.6K | -849K | |
FINANCING ACTIVITIES | ||||||||||||
-11.8M | -1.1M | -594K | -9.7M | -1.4M | 0.0 | -1.5M | -1.6M | 0.0 | 0.0 | 0.0 | 3.8M | |
8.2M | -3.4M | 2.1M | -5.8M | -4M | -10.9M | -2.2M | -10.2M | -7.7M | -4.3M | -2.1M | -1.4M | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -6.5M | -3.8M | |
-13.2M | -1.1M | -594K | -9.7M | -1.4M | (0.0) | -1.5M | -1.6M | (0.0) | (0.0) | (0.0) | (0.0) | |
-2.2M | 789K | 1.3M | 283K | 112K | 1.9M | 396K | 4K | 0.0 | 0.0 | 0.0 | -3.8M | |
-5.8M | -3.7M | 2.8M | -15.3M | -5.3M | -9.1M | -3.3M | -11.8M | -7.7M | -4.3M | -7.9M | -5.1M | |
CASH FLOW SUMMARY | ||||||||||||
-4M | 4.7M | -4.1M | -11.5M | -2.6M | 17.6M | 2.9M | 5.3M | 759K | 1.2M | 1.5M | 1.6M | |
17.5M | 12.8M | 16.9M | 28.4M | 31M | 13.4M | 10.4M | 5.1M | 4.3M | 3.1M | 1.6M | 0.0 | |
13.5M | 17.5M | 12.8M | 16.9M | 28.4M | 31M | 13.4M | 10.4M | 5.1M | 4.3M | 3.1M | 1.6M | |
11.9M | 1.3M | 19.1M | 4.9M | 2.8M | 22.1M | 5.7M | 16.3M | 8M | 4.7M | 9.2M | 6.7M |
SEC Filings
VMD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | June 02, 2026 | June 02, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 05, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 05, 2026 | May 05, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 22, 2026 | April 22, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 16, 2026 | March 16, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 04, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 04, 2026 | March 04, 2026 | 2026 | |
8-K 8-K 2025 N/A | November 07, 2025 | November 07, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 05, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 05, 2025 | November 05, 2025 | 2025 |
Related Guides
Continue your VMD research with focused valuation guides.
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.